A Study of the Safety, Tolerability, and Pharmacokinetics of MEDI0618 in Healthy Volunteers

Trial Identifier: D7060C00001
Sponsor: AstraZeneca
NCTID:: NCT04198558
Start Date: November 2019
Primary Completion Date: February 2022
Study Completion Date: February 2022
Condition: Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
DE Berlin, DE, 10117